Table 2.
Perioperative and postoperative outcomes and complications, oncological and functional control in ORP group and AORP group.
| Characteristic | ORP (n=105) | AORP (n=115) | p-Value |
|---|---|---|---|
| Operative time median (IQR), min | 150 (120–180) | 140 (120–150) | 0.14a |
| Anastomosis time, median (IQR), min | 25 (20–30) | 20 (15–30) | 0.005a |
| Estimated blood loss, median (IQR), mL | 500 (300–600) | 300 (200–500) | 0.0003a |
| Hospitalization, median (IQR), day | 3 (3–4) | 3 (3–4) | 0.16a |
| Days with drain, median (IQR) | 3 (2–4) | 3 (2–4) | 0.09a |
| Days with indwelling bladder catheter, median (IQR) | 14 (14–15) | 7 (7–7) | <0.0001a |
| Nerve sparing, n (%) | 0.0009b | ||
| Absent | 34 (32.4) | 14 (12.2) | |
| Unilateral | 46 (43.8) | 59 (51.3) | |
| Bilateral | 25 (23.8) | 42 (36.5) | |
| Surgical complication, n (%) | 0.007b | ||
| Absent | 76 (72.4) | 100 (87.0) | |
| Present | 29 (27.6) | 15 (13.0) | |
| Clavien-Dindo classification, n (%) | 0.0006b | ||
| Grade I | 2 (1.9) | 7 (6.1) | |
| Grade II | 18 (17.1) | 3 (2.6) | |
| Grade III | 9 (8.6) | 5 (4.3) | |
| Gleason score, n (%) | 0.11b | ||
| 6 | 15 (14.3) | 22 (19.1) | |
| 7 | 79 (75.2) | 72 (62.6) | |
| 8 or 9 | 11 (10.5) | 21 (18.3) | |
| Pathologic stage, n (%) | 0.22b | ||
| pT2a | 4 (3.8) | 11 (9.6) | |
| pT2b | 12 (11.4) | 17 (14.8) | |
| pT2c | 68 (64.8) | 60 (52.2) | |
| pT3a | 7 (6.7) | 13 (11.3) | |
| pT3b | 14 (13.3) | 14 (12.2) | |
| Lymph node, n (%) | 0.28b | ||
| Negative | 65 (98.5) | 82 (95.3) | |
| Positive | 1 (1.5) | 4 (4.7) | |
| Surgical margin, n (%) | |||
| T2 negative | 64 (76.2) | 66 (75.0) | 0.85b |
| T2 positive | 20 (23.8) | 22 (25.0) | |
| T3 negative | 12 (57.1) | 19 (70.4) | 0.34b |
| T3 positive | 9 (42.9) | 8 (29.6) | |
| Biochemical recurrence, n (%) | 0.69b | ||
| Negative | 94 (89.5) | 101 (87.8) | |
| Positive | 11 (10.5) | 14 (12.2) | |
| Continence, n (%) | 0.007b | ||
| Absent | 60 (57.1) | 45 (39.1) | |
| Present | 45 (42.9) | 70 (60.9) | |
| Sexual potency, n (%) | 0.34b | ||
| Absent | 94 (89.5) | 98 (85.2) | |
| Present | 11 (10.5) | 17 (14.8) |
IQR, interquartile range; ORP, open retrograde radical retropubic prostatectomy; AORP, open anterograde anatomic radical retropubic prostatectomy.
a
Mann-Whitney U test.
b
Chi-square or Fisher's exact test.